SCHEMBL11352189

SCHEMBL11352189

O=C(Nc1ccc(C(=O)Nc2ccc3cc(S(=O)(=O)O)ccc3c2O)cc1)Nc1ccc(C(=O)Nc2ccc3cc(S(=O)(=O)O)ccc3c2O)cc1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TIMP3 P35625 4/20 0.57
FGF1 P05230 1/20 0.57
PRMT1 Q99873 2/20 0.54
CASP6 P55212 1/20 0.52
CTDSP1 Q9GZU7 1/20 0.52
ENPP2 Q13822 8/20 0.52
CD40 P25942 1/20 0.48
CD40LG P29965 1/20 0.48
F11 P03951 1/20 0.47
APEX1 P27695 1/20 0.46
SIRT1 Q96EB6 1/20 0.46
NT5E P21589 1/20 0.45
MEN1 O00255 1/20 0.45
USP2 O75604 1/20 0.45
ALDH1A1 P00352 1/20 0.45
RECQL P46063 1/20 0.45
KMT2A Q03164 1/20 0.45
HSD17B10 Q99714 1/20 0.45
TDP1 Q9NUW8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10907420 0.93 CASP6 (0.52) TIMP3FGF1PRMT1CASP6CTDSP1
SCHEMBL11351829 0.92 TIMP3 (0.58) TIMP3FGF1PRMT1CASP6CTDSP1
SCHEMBL11342174 0.87 TIMP3 (0.61) TIMP3FGF1PRMT1CASP6ENPP2
SCHEMBL11425433 0.87 CASP6 (0.62) TIMP3FGF1PRMT1CASP6CTDSP1
SCHEMBL11343087 0.85 TIMP3 (0.47) TIMP3FGF1PRMT1CASP6CTDSP1
SCHEMBL10909096 0.84 TIMP3 (0.50) TIMP3FGF1PRMT1CASP6CTDSP1
SCHEMBL10823703 0.84 PRMT1 (0.55) TIMP3PRMT1CASP6ENPP2CD40
SCHEMBL11431241 0.84 MAPT (0.55) CASP6CTDSP1CD40CD40LGAPEX1
SCHEMBL11350531 0.83 PRMT1 (0.57) TIMP3FGF1PRMT1CASP6CTDSP1
SCHEMBL11340814 0.83 PRMT1 (0.52) TIMP3FGF1PRMT1CASP6ENPP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4297372-A ANTIARTHRITIC AGENTS; COLLAGENASE AND PROTEOLYTIC ENZYME INHIBITORS; BONE, SKIN, AND ORAL DISORDERS AMERICAN CYANAMID COMPANY (US) 1981-10-27 US disclosed
EP-0013784-A1 C-Substituted naphthalenemonosulfonic ureides, process for their preparation and pharmaceutical compositions containing them AMERICAN CYANAMID COMPANY (US) 1980-08-06 EP disclosed
US-4216164-A Ureide inhibitors of connective tissue destruction AMERICAN CYANAMID COMPANY (US) 1980-08-05 US disclosed